Why gene therapy for sickle cell is slow to catch on with patients
By Deena Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into...
By Deena Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into...
By Milana Vinn and David French (Reuters) – Buyout firm TPG has emerged as the...
By Caroline Valetkevitch and Sruthi Shankar NEW YORK/LONDON (Reuters) – Global stock indexes hit all-time...
By Georgina McCartney HOUSTON (Reuters) – Oil prices edged higher on Friday, but were set...
By Jasper Ward and Kanishka Singh WASHINGTON (Reuters) -Former U.S. President Donald Trump, who is...
By Abigail Summerville NEW YORK (Reuters) – Morgan Stanley’s middle-market buyout arm is exploring a...
(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange...
By Nick Carey, Nora Eckert and Joseph White LONDON/DETROIT (Reuters) – Stellantis wants to adopt...
By Niket Nishant and Manya Saini (Reuters) -The U.S. IPO market has bounced back strongly...
(Reuters) – The Federal Communications Commission on Thursday finalized a $6 million fine for a...